⌘K

Login Start Free

Home/Filings/4/0001209191-21-024886

4//SEC Filing

Goater Jeff 4

Accession 0001209191-21-024886

CIK 0001718108other

View on SEC.gov Company Profile

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 8:25 PM ET

Size

12.4 KB

Accession

0001209191-21-024886

Insider Transaction Report

Form 4

Period: 2021-04-01

Surface Oncology, Inc.SURF

DirectorChief Executive Officer

Transactions

Award
Stock Option (Right to Buy)
2021-04-01+15,000→ 15,000 total
Exercise: $8.09Exp: 2031-04-01→ Common Stock (15,000 underlying)
Award
Stock Option (Right to Buy)
2021-04-01+4,425→ 4,425 total
Exercise: $8.09Exp: 2031-04-01→ Common Stock (4,425 underlying)
Award
Stock Option (Right to Buy)
2021-04-01+15,000→ 15,000 total
Exercise: $8.09Exp: 2031-04-01→ Common Stock (15,000 underlying)
Award
Stock Option (Right to Buy)
2021-04-01+35,400→ 35,400 total
Exercise: $8.09Exp: 2031-04-01→ Common Stock (35,400 underlying)

Footnotes (4)

[F1]This option vests monthly through the earlier of (i) September 30, 2021 and (ii) the last date of the reporting person's last day of their Service Relationship
[F2]This option vests monthly through the earlier of (i) March 31, 2022 and (ii) the last date of the reporting person's last day of their Service Relationship.
[F3]This option shall vest in full on March 31, 2022; subject to the reporting person's Service Relationship on such date.
[F4]This option shall vest monthly from April 1, 2022 through the earlier of (i) June 30, 2022 and (ii) the last date of reporting person's Service Relationship.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Surface Oncology, Inc.

CIK 0001718108

Entity typeother

Related Parties

1

filerCIK 0001656435

Filing Metadata

Form type: 4
Filed: Apr 1, 8:00 PM ET
Accepted: Apr 2, 8:25 PM ET
Size: 12.4 KB

View on SEC.gov